These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9492043)

  • 21. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of insulin-like growth factor-I signaling by ethanol in neuronal cells.
    Hallak H; Seiler AE; Green JS; Henderson A; Ross BN; Rubin R
    Alcohol Clin Exp Res; 2001 Jul; 25(7):1058-64. PubMed ID: 11505033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
    Abramovitch S; Werner H
    Horm Metab Res; 2003; 35(11-12):758-62. PubMed ID: 14710355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
    Werner H; Maor S
    Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
    Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
    Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner.
    Bentov I; Narla G; Schayek H; Akita K; Plymate SR; LeRoith D; Friedman SL; Werner H
    Endocrinology; 2008 Apr; 149(4):1890-7. PubMed ID: 18174288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.
    Werner H; Karnieli E; Rauscher FJ; LeRoith D
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8318-23. PubMed ID: 8710868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
    Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
    Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R.
    Raile K; Klammt J; Schneider A; Keller A; Laue S; Smith R; Pfäffle R; Kratzsch J; Keller E; Kiess W
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2264-71. PubMed ID: 16569742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
    Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
    BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of insulin-like growth factor II signaling by mutant type p53: physiological implications for potentiation of IGF-II signaling by p53 mutant 249.
    Lee YI; Han YJ; Lee SY; Lee YI; Park SK; Park YJ; Moon HB; Shin JH; Lee JH
    Mol Cell Endocrinol; 2003 May; 203(1-2):51-63. PubMed ID: 12782403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes.
    Hallak H; Moehren G; Tang J; Kaou M; Addas M; Hoek JB; Rubin R
    Hepatology; 2002 Dec; 36(6):1509-18. PubMed ID: 12447877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene.
    Abramovitch S; Glaser T; Ouchi T; Werner H
    FEBS Lett; 2003 Apr; 541(1-3):149-54. PubMed ID: 12706836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
    Ohashi H; Adachi Y; Yamamoto H; Taniguchi H; Nosho K; Suzuki H; Arimura Y; Imai K; Carbone DP; Shinomura Y
    Cancer Sci; 2012 Feb; 103(2):252-61. PubMed ID: 22044563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells.
    Li T; Chen YH; Liu TJ; Jia J; Hampson S; Shan YX; Kibler D; Wang PH
    Circ Res; 2003 Dec; 93(12):1202-9. PubMed ID: 14593001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.
    Chen WF; Lau WS; Cheung PY; Guo DA; Wong MS
    Br J Pharmacol; 2006 Mar; 147(5):542-51. PubMed ID: 16415910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.